INVESTINGBiotech Trading 2014 Starts Hot, But Surprise, Last Year Was Even BetterBy Adam FeuersteinJan 9, 2014 11:13 AM EST
STOCKSBiotech Stock Mailbag: Bubble Debate, Cel-Sci, Zogenix, ZalicusBy Adam FeuersteinOct 4, 2013 6:00 AM EDT
STOCKSGreater Fools Love Delcath, Zalicus On Orphan Drug DerpitudeBy Adam FeuersteinOct 2, 2013 12:03 PM EDT
STOCKSAcadia Pharma Selling Stock Ahead of Key Study ResultsBy Adam FeuersteinNov 6, 2012 12:54 PM EST
STOCKSHorizon Pharma: Rayos FDA Approval Thursday Seems LikelyBy Adam FeuersteinJul 25, 2012 10:15 AM EDT
